Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
This study has been terminated.
Study NCT00005098   Information provided by National Center for Research Resources (NCRR)
First Received: April 6, 2000   Last Updated: June 23, 2005   History of Changes

April 6, 2000
June 23, 2005
March 1999
 
 
 
Complete list of historical versions of study NCT00005098 on ClinicalTrials.gov Archive Site
 
 
 
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
 

OBJECTIVES:

I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.

PROTOCOL OUTLINE:

Patients undergo blood draw and skin biopsy. Cells are isolated from patients' blood and skin, cell lines are established, and genetic traits are examined.

 
Observational
Screening
Alpha 1-Antitrypsin Deficiency
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Terminated
160
 
 

- Alpha 1-antitrypsin deficiency

Both
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00005098
 
199/14810, WUSM-930603
National Center for Research Resources (NCRR)
Children's Hospital of Pittsburgh
Study Chair: David H. Perlmutter Children's Hospital of Pittsburgh
National Center for Research Resources (NCRR)
May 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP